glp-1 conference Yet another large database study is tying drugs to potential benefits in cancer, suggesting that some patients prescribed the medications after cancer diagnosis have a significantly decreased rate of progression to GLP-1 Agonists: More Than Just
Description
Biological and functional multimorbidityfrom mechanisms to management
It contains the same active drug as Zepbound and Mounjaro but is not FDA-approved
Ohneda, A
To assess risk variation over time, we stratified the analyses on 0-1 year and 0-3 years by splitting the data on follow up time
BioWorld - Saturday, July 18, 2026 Breaking News: Best of BioWorld Science: Q2See today's BioWorld Science Home Gilead Sciences describes new GLP-1R agonists To read the full story, subscribe or sign in
, Semaglutide in Patients With Heart Failure With Preserved Ejection Fraction and Obesity, New England Journal of Medicine 389, no
